# Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

> **NCT07380867** · NA · ENROLLING_BY_INVITATION · sponsor: **Seoul St. Mary's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Cancer
- Endoscopic Tattoo of Suspected Colon Cancer
- Indocyanine Green (ICG)

## Interventions

- **DRUG:** LuminoMark inj. 0.2mL

## Key facts

- **NCT ID:** NCT07380867
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380867, "Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07380867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*